Journal Article > CommentaryFull Text
Southern African Journal of HIV medicine. 2012 March 1
Andrieux-Meyer I, Clayden P, Collins S, Geffen N, Goemaere E, et al.
Southern African Journal of HIV medicine. 2012 March 1
Journal Article > CommentaryFull Text
J Int AIDS Soc. 2012 September 18; Volume 15; DOI:10.7448/IAS.15.2.17986
Andrieux-Meyer I, Calmy A, Cahn P, Clayden P, Raguin G, et al.
J Int AIDS Soc. 2012 September 18; Volume 15; DOI:10.7448/IAS.15.2.17986
Global commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission. Increasingly, countries are adapting their national guidelines to start ART earlier, for both clinical and preventive benefits. To maximize the benefits of ART in resource-limited settings, six key principles need to guide ART choice: simplicity, tolerability and safety, durability, universal applicability, affordability and heat stability. Currently available drugs, combined with those in late-stage clinical development, hold great promise to simplify treatment in the short term. Over the longer-term, newer technologies, such as long-acting formulations and nanotechnology, could radically alter the treatment paradigm. This commentary reviews recommendations made in an expert consultation on treatment scale up in resource-limited settings.
Journal Article > LetterAbstract Only
Lancet HIV. 2024 October 1; Volume 11 (Issue 10); e711-e716.; DOI:10.1016/S2352-3018(24)00173-5
Venter WDF, Gandhi M, Sokhela S, Sikwese K, Bygrave H, et al.
Lancet HIV. 2024 October 1; Volume 11 (Issue 10); e711-e716.; DOI:10.1016/S2352-3018(24)00173-5